Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.54M Sell
9,663
-2,467
-20% -$412K ﹤0.01% 3162
2014
Q2
$2.11M Buy
12,130
+5,037
+71% +$751K ﹤0.01% 2818
2014
Q1
$1.03M Sell
7,093
-2,673
-27% -$393K ﹤0.01% 3461
2013
Q4
$1.05M Sell
9,766
-17,887
-65% -$1.64M ﹤0.01% 3491
2013
Q3
$2.17M Buy
27,653
+20,765
+301% +$1.59M ﹤0.01% 2492
2013
Q2
$501K Buy
+6,888
New +$441K ﹤0.01% 4103

Other funds holding ILMN

UBS's ILMN Position: Q3 2014 in Review

UBS reduced its Illumina (ILMN) stake by 12% in Q3 2014, selling an estimated $3.47M and leaving 158,675 shares worth $25.3M. The position accounts for 0.02% of the portfolio, ranked #808.

UBS first reported a position in ILMN in Q2 2013 and has held it in 6 quarters since. The position peaked at $31.2M in Q2 2014. 480 funds tracked by Wall St. Rank hold ILMN as of Q3 2014.

  • UBS held 158,675 shares of Illumina worth $25.3M as of Q3 2014.
  • UBS sold 20,742 Illumina shares in Q3 2014, an estimated $3.47M.
  • Illumina made up 0.02% of UBS's portfolio in Q3 2014, its #808 holding.
  • UBS first reported a position in Illumina in Q2 2013 and has held it in 6 quarters since.
  • UBS's Illumina position peaked at $31.2M in Q2 2014.
  • 480 funds tracked by Wall St. Rank held Illumina as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.